Clinical trial Recruiting at 15 sites Observational Ages 12 to 35

Genetic assessment of young athletes who experience sudden cardiac arrest during sports

Official title: Registre Prospectif français Des Morts Subites Chez Des Sportifs Jeunes

Run by Rennes University Hospital · NCT06642168 · Data updated 2026-11-12

This study looks at young athletes aged 12 to 35 who have had sudden cardiac arrest during sports to see if genetic factors played a role and to help prevent similar events in others.

More Sudden Cardiac Death trials

Quick facts

Study typeObservational
Ages12 Years to 35 Years
SexAll
Enrollment80 (estimated)
SponsorRennes University Hospital
Academic / other
Locations26 sites (Nîmes, France and 25 other locations)
StatusRecruiting
StartedOctober 11, 2024
Main results expectedJanuary 11, 2028
Study endsJanuary 11, 2028
Registry record updatedAugust 25, 2026
Trial IDNCT06642168 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are young athletes aged 12 to 35 who have experienced a sudden cardiac arrest during or shortly after sports activities without any known cardiovascular pathology.

Probably not a fit

Patients who have pre-existing cardiovascular conditions or are older than 35 years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry focuses on young individuals aged 12 to 35 who suffer from sudden cardiac arrest (SCA) or sudden cardiac death (SCD) related to sports activities. The study aims to identify the underlying causes of these events through comprehensive etiological assessments, including autopsies, whole exome genetic analysis, and toxicological testing. By understanding the genetic factors involved, the study seeks to provide insights that could help prevent similar incidents in family members of victims. The findings will contribute to a better understanding of the risks associated with sports participation in young athletes.

Why it matters

Potential benefit: If successful, this study could lead to improved prevention strategies for sudden cardiac events in young athletes and their families.

How similar studies have gone: While studies on sudden cardiac arrest in athletes exist, this specific approach focusing on genetic assessment in young victims is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Victims of SCA:

  * Aged between 12 and 35 years
  * No known cardiovascular pathology
  * Experienced a sudden and non-traumatic SCA during or within one hour of participating in sports activities (leisure, training, or competition)
  * For resuscitated victims (SCA group): A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, organs, or authorities responsible for assisting or representing them if they are unable to express their wishes).
  * For non-resuscitated victims (SCD group): A person who has not formally objected to the reuse of their medical data during their lifetime.
* First-Degree Relatives:

  * A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, bodies, or authorities responsible for assisting or representing them if they are unable to express their wishes).

Non-Inclusion Criteria:

* For resuscitated SCA cases, individuals weighing less than 20 kg
* Victims or legal representatives who are subject to legal protection or deprived of their liberty

Where it's running

  • APHP Hôpital Européen Georges Pompidou
    Paris, France, France
    Recruiting
  • CHU Rennes
    Rennes, France, France
    Recruiting
  • CHU Bordeaux
    Bordeaux, France
    Recruiting
  • CHU Caen
    Caen, France
    Recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting
  • CHRU Lille
    Lille, France
    Recruiting
Show 20 more locations
  • APHM Hôpitaux universitaires de Marseille
    Marseille, France
    Recruiting
  • CHRU Montpellier
    Montpellier, France
    Recruiting
  • CHU Nantes
    Nantes, France
    Recruiting
  • CHU de Nice
    Nice, France
    Recruiting
  • APHP Hôpital Pitié-Salpêtrière
    Paris, France
    Recruiting
  • CHU Poitiers
    Poitiers, France
    Recruiting
  • CHU Saint-Etienne
    Saint-Etienne, France
    Recruiting
  • CHU Toulouse
    Toulouse, France
    Recruiting
  • CHRU Tours
    Tours, France
    Recruiting
  • CHU Nîmes
    Nîmes, France, France
    Not yet recruiting
  • APHP Hôpital Bichat
    Paris, France, France
    Not yet recruiting
  • CHU Brest
    Brest, France
    Not yet recruiting
  • APHP Hôpital Henri-Mondor
    Créteil, France
    Not yet recruiting
  • CHU Dijon Bourgogne
    Dijon, France
    Not yet recruiting
  • CHU de Grenoble Alpes
    Grenoble, France
    Not yet recruiting
  • Hospices Civils de Lyon
    Lyon, France
    Not yet recruiting
  • CHRU Nancy
    Nancy, France
    Not yet recruiting
  • CHU Reims
    Reims, France
    Not yet recruiting
  • CHU Rouen
    Rouen, France
    Not yet recruiting
  • CHRU Strasbourg
    Strasbourg, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.